Completed PHASE1 INTERVENTIONAL NCT01338051

The Development of a Mother/Child, Screen, Treat and Vaccinate Program in Manchay and Iquitos, Peru (PERCAPS)

Sponsor: Merck Sharp & Dohme LLC

Conditions Cervical Cancer Cervical Dysplasia Cervical Intraepithelial Neoplasia Cervical Neoplasm Human Papillomavirus

Interventions Gardasil

Updated 6 times since 2017 Last updated: Apr 16, 2014 Started: May 31, 2011 Primary completion: Apr 30, 2012 Completion: Apr 30, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1 trial investigates Cervical Cancer and Cervical Dysplasia and is currently completed. Merck Sharp & Dohme LLC leads this study, which shows 6 recorded versions since 2011 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jun 2022 — Jul 2024 [monthly]

Completed PHASE1
Jan 2021 — Jun 2022 [monthly]

Completed PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE1

First recorded

May 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Merck Sharp & Dohme LLC
Peru Instituto Nacional de Enfermadades Neoplasticas (INEN)
Preventive Oncology International, Inc.

Data source: Preventive Oncology International, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Iquitos, Peru
• Manchay, Peru